ROCHE WN42171

Back to Drug Development Trials
Drug Development Trials

About the trial

An open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term gantenerumab administration in participants with Alzheimer’s disease.

View study